Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
Public ClinicalTrials.gov record NCT03407716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ginseng as an Intervention to Decrease Cancer-Related Fatigue in Post-Treatment Cancer Survivors: A Randomized Controlled Pilot Study
Study identification
- NCT ID
- NCT03407716
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Mayo Clinic
- Other
- Enrollment
- 2 participants
Conditions and interventions
Conditions
- Cancer Survivor
- Stage I Breast Cancer AJCC v7
- Stage I Colon Cancer AJCC v6 and v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage II Colon Cancer AJCC v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIA Colon Cancer AJCC v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Stage IIB Colon Cancer AJCC v7
- Stage IIC Colon Cancer AJCC v7
- Stage III Breast Cancer AJCC v7
- Stage III Colon Cancer AJCC v7
- Stage IIIA Breast Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIB Breast Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIC Breast Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7
Interventions
- American Ginseng Drug
- Laboratory Biomarker Analysis Other
- Placebo Other
- Questionnaire Administration Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2019
- Primary completion
- May 12, 2020
- Completion
- Feb 21, 2021
- Last update posted
- Jan 4, 2023
2019 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03407716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2023 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03407716 live on ClinicalTrials.gov.